The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells
Year: 2019
Type: article
Source: Journal of Cellular Biochemistry
DOI: 10.1002/jcb.28929
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Astellas Pharma
OpenAlex ID: W2961546954
